Deep Breath Intelligence Inc
Rotkreuz, Switzerland, June 1 /PRNewswire/
Swiss startup Deep Breath Intelligence AG (DBI) ( www.dbi.ch) Won the first prize among two hundred competitors. With its annual awards ceremony, the Technologie Forum Zug offers young companies a platform to showcase their revolutionary business ideas.
The goal of DBI is the early detection and accurate treatment of diseases through molecular breathing analysis. The leading technology has been developed at Yale, ETH, University Hospital Zurich, UZH, UKBB and University of Basel. The company uses artificial intelligence to find specific molecules (biomarkers) in the air we breathe. DBI technology can detect one molecule in a trillion – roughly equivalent to one drop in a 50-meter Olympic swimming pool. The measurement is completely non-invasive and painless and the result is delivered instantly in real time.
The core team is led by CEO Christian Zwicky and includes experts in the fields of MedTech, Diagnostics, Clinical and Analytical Knowledge, and Data Science (ML/AI). Founders Professor Dr. Pablo Senos (Professor at the University of Basel and lecturer at ETH Zurich), Prof. Dr. Malcom Kohler (Director of USZ Pulmonology) and investor Paul Schenker.
Contact:
Christian Zwicky
Deep Breath Intelligence Inc
Suurstuffy 29
CH – 6343 Rotcruise
Phone number +41 (0) 79460 16 17
Email [email protected]
:Logo: https://mma.prnewswire.com/media/1815439/DBI_Logo.jpg
Original content from: Deep Breath Intelligence AG, transmitted via aktuell news
“Certified tv guru. Reader. Professional writer. Avid introvert. Extreme pop culture buff.”
More Stories
Bluetooth Auracast: This is what the new technology brings
Why is ethics so important in AI?
Technology – Hessen Signals accommodates central cyber authority